Patients usually share the same phenotype of both PRKN and PINK1 cases, presenting early onset slowly progressive Parkinsonism (mean age 27 years), good response to dopaminergic therapy, frequent focal dystonia, motor complications upon treatment, and psychiatric symptoms, in particular anxiety that often presents as the first symptom (73, 132). This evidence concerns the gene PINK1 and Parkinsonism.